These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3252039)

  • 1. Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent.
    Kitzen JM; Lynch JJ; Driscoll EM; Lucchesi BR
    J Pharmacol Exp Ther; 1988 Mar; 244(3):929-39. PubMed ID: 3252039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive chronotropic and inotropic effects of pimobendan (UD-CG 115 BS) in isolated, cross-circulated canine heart preparations.
    Furukawa Y; Akahane K; Ogiwara Y; Haniuda M; Chiba S
    Arch Int Pharmacodyn Ther; 1989; 300():159-73. PubMed ID: 2575887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of intravenous UD-CG 115 BS (pimobendan) on the cardiovascular system and left ventricular pump function.
    Permanetter B; Sebening H; Hartmann F; Klein G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S36-40. PubMed ID: 2478790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic profile of the cardiotonic agent pimobendan.
    van Meel JC; Diederen W
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S1-6. PubMed ID: 2478784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pimobendan (UD-CG 115 BS) on left ventricular inotropic state in conscious dogs and in patients with heart failure.
    Pouleur H; Hanet C; Schröder E; Col J; Van Mechelen H; Etienne J; Rousseau MF
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S18-22. PubMed ID: 2478787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reduction in left ventricular volume and improvement in hemodynamics following intravenous administration of pimobendan (UDGG 115 BS) in dilated cardiomyopathy].
    Permanetter B; Sebening H; Busch U; Lutilsky L
    Z Kardiol; 1990 Aug; 79(8):565-72. PubMed ID: 2220013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril.
    Hauf GF; Grom E; Jähnchen E; Roskamm H
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S49-56. PubMed ID: 2478793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of the positive inotropic agents pimobendan and sulmazole in vivo.
    von Meel JC
    Arzneimittelforschung; 1985; 35(1A):284-8. PubMed ID: 4039168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of intravenous pimobendan in patients with left ventricular dysfunction.
    Remme WJ; Wiesfeld AC; Look MP; Kruyssen HA
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S41-4. PubMed ID: 2478791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S23-30. PubMed ID: 2478788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise.
    Stubenitsky R; van der Weerd RW; Haitsma DB; Verdouw PD; Duncker DJ
    Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparate inotropic and lusitropic responses to pimobendan in conscious dogs with tachycardia-induced heart failure.
    Asanoi H; Ishizaka S; Kameyama T; Ishise H; Sasayama S
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):268-74. PubMed ID: 7511757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
    Kopia GA; Ohlstein EH; Ruffolo RR
    J Pharmacol Exp Ther; 1988 Aug; 246(2):434-40. PubMed ID: 3404441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in Ca(2+)-sensitizing effect of UD-CG 212 Cl, a metabolite of pimobendan, under acidotic condition in canine ventricular myocardium.
    Takahashi R; Shimazaki Y; Endoh M
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1060-6. PubMed ID: 11504803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic haemodynamic actions of pimobendan (UD-CG 115 BS) and its O-demethylmetabolite UD-CG 212 Cl in the conscious pig.
    Duncker DJ; Hartog JM; Levinsky L; Verdouw PD
    Br J Pharmacol; 1987 Jul; 91(3):609-15. PubMed ID: 3607369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pimobendan on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy: comparison with nitroprusside.
    Hasenfuss G; Holubarsch C; Heiss HW; Allgeier M; Just H
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S31-5. PubMed ID: 2478789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular profile of pimobendan, a benzimidazole-pyridazinone derivative with vasodilating and inotropic properties.
    Verdouw PD; Hartog JM; Duncker DJ; Roth W; Saxena PR
    Eur J Pharmacol; 1986 Jul; 126(1-2):21-30. PubMed ID: 2875884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction.
    Lynch JJ; Kitzen JM; Hoff PT; Lucchesi BR
    J Cardiovasc Pharmacol; 1988; 12(5):547-54. PubMed ID: 2468054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.